slump sale

  1. H

    Sebi Confirms Investigation into Par Drugs' Slump Sale

    Sebi Confirms Restrictions on Par Drugs’ Proposed Slump Sale Regulatory Action Pending Investigation New Delhi, March 26 – The Securities and Exchange Board of India (Sebi) has confirmed its previous directions against Par Drugs and Chemicals Ltd (PDCL) regarding a proposed slump sale of its...
  2. K

    Reva Diamond Jewellery IPO Shares Fall on Market Downturn

    PNGS Reva Diamond Jewellery Shares List at Discount, Debut Amid Market Selloff PNGS Reva Diamond Jewellery IPO Listing Details Shares of PNGS Reva Diamond Jewellery Ltd made a subdued debut on the stock exchanges on March 4, listing at a discount of nearly 4 percent to the issue price of Rs 386...
  3. K

    PNGS Reva Diamond Jewellery Shares List at Discount on BSE and NSE After ₹380 Crore IPO

    PNGS Reva Diamond Jewellery Shares List at Discount on BSE and NSE After ₹380 Crore IPO PNGS Reva Diamond Jewellery made a muted debut on the stock exchanges on Wednesday, March 4, as the stock listed below its issue price on both the BSE and NSE.PNGS Reva Diamond Jewellery Listing Price on...
  4. K

    New Retail Jewellery Brand, PNGS Reva, Launches IPO

    PNGS Reva Diamond Jewellery IPO Subscribed 1.23 Times on Final Day; Retail and NII Segments Lead Demand The initial public offering of PNGS Reva Diamond Jewellery Ltd was subscribed 1.23 times on Thursday, the final day of bidding, reflecting moderate investor participation across categories...
  5. K

    PNGS Reva Diamond Jewellery IPO Subscribed 83% on Day 2; QIB Portion Nears Full Subscription

    PNGS Reva Diamond Jewellery IPO Subscription Status The initial public offering of PNGS Reva Diamond Jewellery Ltd witnessed steady investor interest on the second day of bidding on Wednesday, with the issue subscribed 83 per cent overall.According to NSE data, the IPO received bids for...
Back
Top